Eltrombopag Olamine (Standard)
Eltrombopag (Olamine) (Standard) is the analytical standard of Eltrombopag (Olamine). This product is intended for research and analytical applications. Eltrombopag Olamine (Eltrombopag diethanolamine salt) is an orally active thrombopoietin receptor nonpeptide agonist. Eltrombopag Olamine owns thrombopoietic activity, and has been used to research low blood platelet counts with chronic immune thrombocytopenia. Eltrombopag Olamine can be used for the research of cardiovascular. Eltrombopag Olamine also has highly inhibitory effects against multidrug resistant Staphylococcus aureus. Eltrombopag Olamine can induce apoptosis in hepatocellular carcinomab (HCC) as well.
For research use only. We do not sell to patients.
- Purity : 98%
- CAS No.: 496775-62-3
- Formula: C29H36N6O6
- Molecular Weight:564.63
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 496775-62-3
-
Molecular Weight 564.63
-
Formula C29H36N6O6
-
SMILES
O=C(C1=CC(C2=CC=CC(N/N=C3C(C)=NN(C4=CC=C(C)C(C)=C4)C/3=O)=C2O)=CC=C1)O.NCCO.NCCO
-
Synonyms
Eltrombopag diethanolamine salt (Standard); SB-497115GR (Standard)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Eltrombopag Olamine (Standard)
- 496775-62-3
- Eltrombopag diethanolamine salt (Standard)
- SB-497115GR (Standard)
- Reference Standards
- Thrombopoietin Receptor
- Bacterial
- Apoptosis
- immune thrombocytopenia
- blood platelet
- hematopoiesis
- megakaryocyte
- N2C-Tpo
- CD34
- BAF3
- chimpanzee
- hepatocellular carcinomab
- Inhibitor
- inhibitor
- inhibit